Gunnar Magnus Modee Persson
Voorzitter bij INITIATOR PHARMA A/S
Vermogen: 57 795 $ op 30-04-2024
Oorsprong van het eerstegraads netwerk van Gunnar Magnus Modee Persson
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Karolinska Institutet
123
| College/University | Other Consumer Services | 123 |
| Public Company | Pharmaceuticals: Major | 47 | |
22
| Public Company | Biotechnology | 22 |
22
| Public Company | Pharmaceuticals: Major | 22 |
| Public Company | Financial Conglomerates | 15 | |
Allarity Therapeutics A/S
 Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark.
14
| Private Company | Pharmaceuticals: Major | 14 |
HealthCap AB
 HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland.
14
| Subsidiary | Investment Managers | 14 |
Galecto Biotech ApS
 Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark.
14
| Subsidiary | Pharmaceuticals: Major | 14 |
Gyros AB
 Gyros AB Medical SpecialtiesHealth Technology Gyros AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. Its Gyrolab xP miniaturizes, integrates, and automates analysis of samples in parallel. The firm's technology delivers immunoassay data through automated control of centrifugal and capillary forces to steer liquid flow in proprietary nanoliter-scale microfluidic structures.The company offers Gyrolab microlaboratory, in the form of a compact disk, can process samples at nanoliter scale, controlled by Gyrolab Workstation. Gyros was founded in 2000 and is headquartered in Uppsala, Sweden.
10
| Subsidiary | Medical Specialties | 10 |
| Public Company | Pharmaceuticals: Major | 10 | |
| Public Company | Pharmaceuticals: Major | 4 | |
Albumedix A/S
 Albumedix A/S Pharmaceuticals: MajorHealth Technology Albumedix A/S is a Danish biotechnology company. The private company is based in Copenhagen, Denmark.
2
| Private Company | Pharmaceuticals: Major | 2 |
Medical Prognosis Institute, Inc.
2
| Subsidiary | 2 | |
Perma Ventures AB
 Perma Ventures AB Investment ManagersFinance Perma Ventures AB provides financial advisory services. The private company is based in Stockholm, Sweden.
1
| Private Company | Investment Managers | 1 |
ADDI Medical AB
 ADDI Medical AB Packaged SoftwareTechnology Services ADDI Medical AB develops a communication platform for the healthcare industry. The private company is based in Stockholm, Sweden.
1
| Private Company | Packaged Software | 1 |
Attgeno AB
 Attgeno AB Pharmaceuticals: MajorHealth Technology ATTGENO AB develops, manufactures, and trades pharmaceutical drugs and electronic apparatus. Its product, Supernitro, is a vasodilator indicated for the treatment of acute pulmonary hypertension associated with major cardiac surgery. The company is headquartered in Stockholm, Sweden.
1
| Holding Company | Pharmaceuticals: Major | 1 |
Mordin AB
1
| Private Company | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Gunnar Magnus Modee Persson via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| CELGENE | Biotechnology | Founder Chief Executive Officer Director/Board Member | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Investor Relations Contact | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
| NEXIMMUNE, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| ACTIVE BIOTECH AB | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer Director/Board Member Director/Board Member Investor Relations Contact Chief Executive Officer | |
| MEDIVIR AB | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Royal Swedish Academy of Sciences
 Royal Swedish Academy of Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Sciences provides research and development services on sciences. The non-profit company is based in Stockholm, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Affibody Medical AB
 Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member Founder Director/Board Member | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal | |
| University of Medicine & Dentistry of New Jersey | College/University | Chairman Corporate Officer/Principal Director/Board Member | |
| OREXO AB | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Corporate Officer/Principal | |
| Chalmers University of Technology | College/University | Corporate Officer/Principal Graduate Degree Graduate Degree | |
| Stockholm School of Economics | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree | |
| University of Uppsala | College/University | Doctorate Degree Doctorate Degree Masters Business Admin Corporate Officer/Principal | |
Karolinska Development AB (Private Equity)
 Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development AB (Private Equity) (Karolinska Development) is a Venture Capital firm, a subsidiary of Karolinska Development AB founded in 2003. The firm is headquartered in Solna. | Investment Managers | Chief Executive Officer Chief Executive Officer | |
Newron Sweden AB
 Newron Sweden AB Pharmaceuticals: MajorHealth Technology Newron Sweden AB is a biopharmaceutical company engaged in the development of novel therapies for the treatment of disorders of the central nervous systems. The company was founded by Jonas Cristopher Frisen and Ann Marie Janson in 1998 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member Chairman Founder | |
| ONCOPEPTIDES AB | Pharmaceuticals: Major | Founder Director/Board Member Director of Finance/CFO Corporate Officer/Principal | |
| Royal Institute of Technology | College/University | Corporate Officer/Principal Graduate Degree | |
| University of Lund | College/University | Graduate Degree Corporate Officer/Principal Doctorate Degree Undergraduate Degree Corporate Officer/Principal Doctorate Degree Graduate Degree | |
| University of Copenhagen | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree Doctorate Degree Undergraduate Degree | |
| University of Southern Denmark | College/University | Undergraduate Degree Doctorate Degree | |
| VIVESTO AB | Pharmaceuticals: Generic | Director of Finance/CFO Chairman | |
Aleris Holding AB
 Aleris Holding AB Medical/Nursing ServicesHealth Services Aleris Holding AB engages in health sector. It provides services in healthcare and mental health on behalf of municipalities, county councils and insurance companies. The company was founded in March 2005 and is headquartered in Stockholm, Sweden. | Medical/Nursing Services | Chairman Corporate Officer/Principal | |
Aprea Therapeutics AB
 Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| BIOARCTIC AB | Pharmaceuticals: Major | Founder Director of Finance/CFO Corporate Officer/Principal Director/Board Member | |
| XSPRAY PHARMA AB | Pharmaceuticals: Major | Chairman Director/Board Member | |
SwedenBIO Service AB
 SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services SwedenBIO Service AB is a non-profit company that develops biotechnology, diagnostics, pharmaceuticals, and medical technology. It also offers counseling, education, opinion formation, and investigations. The company was founded in 2002 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
Healthcap 1999 GP AB
 Healthcap 1999 GP AB Investment Banks/BrokersFinance Part of Odlander, Fredrikson & Co. AB, Healthcap 1999 GP AB is a private company that manages and trades securities. The company is based in Stockholm, Sweden. | Investment Banks/Brokers | President Director/Board Member | |
Karolinska University Hospital
 Karolinska University Hospital Hospital/Nursing ManagementHealth Services Karolinska University Hospital is a premier health facility and one of Europe's largest teaching hospitals located in Stockholm, Sweden. The Swedish company provides healthcare services for a wide range of disorders, from major public health diseases to rare medical conditions. As a designated provider of highly specialized medical services, they have a primary responsibility for the clinical components of research and education. Together with the world-respected Karolinska Institutet, they lead in medical breakthroughs. The company educates and train tomorrow's medical specialists and healthcare professionals as a major teaching hospital. | Hospital/Nursing Management | Chairman Corporate Officer/Principal Corporate Officer/Principal | |
| CALMARK SWEDEN AB | Medical Specialties | Director/Board Member Director/Board Member | |
Modus Therapeutics AB
 Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Modus Therapeutics AB operates as a clinical-stage drug development company that develops new pharmaceutical therapies designed to restore impaired blood flow and oxygen transport in diseases with unmet medical needs. The firm’s product Sevuparin, evaluates in a phase II clinical trial in sickle cell disease (SCD) and repeated painful crises in SCD, so called vaso-occlusive crises (VOC) that leads to loss of vital organ function and reduced life span. The company was founded by Carl Mats Wahlgren in 2011 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member | |
Allarity Therapeutics Europe ApS
 Allarity Therapeutics Europe ApS Pharmaceuticals: MajorHealth Technology Allarity Therapeutics Europe ApS operates as a pharmaceutical company that provides oncology products. The firm engages in diagnostics and drug development. The company was founded by Steen Meier Knudsen on August 1, 2012 and is headquartered in Hørsholm, Denmark. | Pharmaceuticals: Major | Chief Executive Officer Founder Director/Board Member | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin Undergraduate Degree | |
| WILSON THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
Glionova AB
 Glionova AB Pharmaceuticals: MajorHealth Technology Glionova AB develops cancer treatment drugs. The firm is a drug discovery and development company. It offers GLN-1001 product. The company was founded by Lars G. J. Hammarström and Patrik Ernfors in 2014 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member Director/Board Member | |
| CORLINE BIOMEDICAL AB | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
Israel Biotech Fund
 Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Investment Managers | Consultant / Advisor Consultant / Advisor | |
| ANNEXIN PHARMACEUTICALS AB | Pharmaceuticals: Major | Chairman Chief Executive Officer Chief Executive Officer | |
| GALECTO, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member Chief Executive Officer | |
| ADHERA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Chief Executive Officer | |
| BACTIGUARD HOLDING AB | Medical Specialties | Director of Finance/CFO Chief Executive Officer Director/Board Member | |
| Actinova AB | Director/Board Member Director/Board Member |
Statistieken
Internationaal
| Zweden | 35 |
| Verenigde Staten | 8 |
| Denemarken | 7 |
| Verenigd Koninkrijk | 2 |
| Nederland | 2 |
Sectoraal
| Health Technology | 33 |
| Consumer Services | 10 |
| Commercial Services | 4 |
| Finance | 4 |
| Health Services | 3 |
Operationeel
| Director/Board Member | 677 |
| Corporate Officer/Principal | 262 |
| Chairman | 174 |
| Independent Dir/Board Member | 153 |
| Chief Executive Officer | 115 |
Sterkste connecties
| Insiders | |
|---|---|
| Björn Ingemar Odlander | 53 |
| Michael Barrett | 49 |
| Søren Lemonius | 39 |
| Garry Neil | 38 |
| Peter Sjöstrand | 35 |
| Johan Rutger Christenson | 35 |
| Frank Torti | 35 |
| Eugene Bauer | 34 |
| Isaac Blech | 32 |
| Sol Barer | 32 |
| Peter Buhl Jensen | 32 |
| Carl Samuel Goldfischer | 31 |
| Hans Lennart Rudolf Wigzell | 30 |
| Nanna Liebach Lüneborg | 29 |
| Anders Olof Adolf Ekblom | 27 |
- Beurs
- Insiders
- Gunnar Magnus Modee Persson
- Bedrijfsconnecties
